Cigna Group (NYSE:CI) Receives Consensus Rating of “Moderate Buy” from Analysts

Cigna Group (NYSE:CIGet Free Report) has received an average recommendation of “Moderate Buy” from the twenty-two brokerages that are currently covering the firm, MarketBeat Ratings reports. Six analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has assigned a strong buy rating to the company. The average 1 year price target among brokers that have updated their coverage on the stock in the last year is $338.30.

Several research firms have recently weighed in on CI. Wolfe Research reaffirmed an “outperform” rating and set a $315.00 price objective on shares of Cigna Group in a report on Tuesday, June 16th. Sanford C. Bernstein raised their price objective on shares of Cigna Group from $358.00 to $371.00 and gave the stock an “outperform” rating in a report on Tuesday, May 5th. Royal Bank Of Canada raised their price objective on shares of Cigna Group from $333.00 to $337.00 and gave the stock an “outperform” rating in a report on Friday, May 1st. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Cigna Group in a report on Monday, June 1st. Finally, Jefferies Financial Group dropped their price objective on shares of Cigna Group from $333.00 to $330.00 and set a “buy” rating for the company in a report on Monday, April 20th.

Read Our Latest Stock Analysis on CI

Insider Buying and Selling

In related news, CEO David Cordani sold 201,878 shares of the firm’s stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total value of $59,113,915.96. Following the completion of the sale, the chief executive officer owned 34,337 shares of the company’s stock, valued at $10,054,560.34. This trade represents a 85.46% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the firm’s stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $298.61, for a total transaction of $268,450.39. Following the completion of the sale, the chief accounting officer directly owned 2,368 shares of the company’s stock, valued at approximately $707,108.48. This represents a 27.52% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 0.60% of the company’s stock.

Institutional Trading of Cigna Group

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Evercore Wealth Management LLC boosted its stake in Cigna Group by 2.8% in the first quarter. Evercore Wealth Management LLC now owns 1,301 shares of the health services provider’s stock valued at $347,000 after acquiring an additional 35 shares during the last quarter. Cary Street Partners Investment Advisory LLC boosted its stake in Cigna Group by 11.0% in the fourth quarter. Cary Street Partners Investment Advisory LLC now owns 363 shares of the health services provider’s stock valued at $100,000 after acquiring an additional 36 shares during the last quarter. OLD National Bancorp IN boosted its stake in Cigna Group by 3.7% in the fourth quarter. OLD National Bancorp IN now owns 1,031 shares of the health services provider’s stock valued at $284,000 after acquiring an additional 37 shares during the last quarter. IHT Wealth Management LLC boosted its stake in Cigna Group by 2.5% in the fourth quarter. IHT Wealth Management LLC now owns 1,535 shares of the health services provider’s stock valued at $423,000 after acquiring an additional 38 shares during the last quarter. Finally, Whetstone Capital Advisors LLC boosted its stake in Cigna Group by 4.9% in the fourth quarter. Whetstone Capital Advisors LLC now owns 829 shares of the health services provider’s stock valued at $228,000 after acquiring an additional 39 shares during the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.

Cigna Group Stock Performance

NYSE:CI opened at $282.84 on Monday. The firm has a market capitalization of $74.82 billion, a PE ratio of 11.99, a price-to-earnings-growth ratio of 1.09 and a beta of 0.28. The firm has a 50-day moving average price of $284.66 and a 200 day moving average price of $278.74. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.69. Cigna Group has a 12-month low of $239.51 and a 12-month high of $338.89.

Cigna Group (NYSE:CIGet Free Report) last posted its quarterly earnings data on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, topping the consensus estimate of $7.60 by $0.19. The company had revenue of $68.52 billion during the quarter, compared to analyst estimates of $66.29 billion. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The company’s revenue was up 4.6% on a year-over-year basis. During the same quarter last year, the business posted $6.74 earnings per share. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Research analysts anticipate that Cigna Group will post 30.39 earnings per share for the current fiscal year.

Cigna Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, June 18th. Investors of record on Thursday, June 4th were issued a $1.56 dividend. The ex-dividend date of this dividend was Thursday, June 4th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. Cigna Group’s dividend payout ratio (DPR) is currently 26.45%.

Cigna Group Company Profile

(Get Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Read More

Analyst Recommendations for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.